Literature DB >> 2920029

Minimum requirements for inhibition of smooth-muscle myosin light-chain kinase by synthetic peptides.

J T Hunt1, D M Floyd, V G Lee, D K Little, S Moreland.   

Abstract

Although the amino acid residues that are important for peptide substrates of myosin light-chain kinase have been reported, those that are important for peptide inhibitors of this enzyme have not previously been investigated. Synthetic peptides based on the sequence Lys11-Lys12-Arg13-Ala-Ala-Arg16-Ala-Thr-Ser19 -Asn-Val21-Phe22-Ala of the chicken gizzard myosin light chain were tested as inhibitors of pig carotid-artery myosin light-chain kinase. The basic amino acid residues of the known myosin light-chain kinase inhibitor Lys-Lys-Arg-Ala-Ala-Arg-Ala-Thr-Ser-NH2 (IC50 = 14 microM) [Pearson, Misconi & Kemp (1986) J. Biol. Chem. 261, 25-27] were shown to be the important residues that contribute to inhibitor potency, as evidence by the finding that the hexapeptide Lys-Lys-Arg-Ala-Ala-Arg-NH2 had an IC50 value of 22 microM. This indicates that binding of the phosphorylatable serine residue to myosin light-chain kinase, which is of obvious importance for a substrate, does not enhance the potency of an inhibitor. With the aim of preparing more potent inhibitors, peptides Lys-Lys-Arg-Ala-Ala-Arg-Ala-Ala-Xaa-NH2 were prepared with a variety of amino acids substituted for the phosphorylatable serine residue. None of these peptides was a more potent inhibitor than the serine peptide.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2920029      PMCID: PMC1135539          DOI: 10.1042/bj2570073

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  24 in total

Review 1.  Binding energy, specificity, and enzymic catalysis: the circe effect.

Authors:  W P Jencks
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1975

2.  [Di-tert.-butyl-dicarbonate, a useful tert.-Butyloxycardonylating reagent (author's transl)].

Authors:  L Moroder; A Hallett; E Wünsch; O Keller; G Wersin
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1976-11

Review 3.  The function of myosin and myosin light chain kinase phosphorylation in smooth muscle.

Authors:  K E Kamm; J T Stull
Journal:  Annu Rev Pharmacol Toxicol       Date:  1985       Impact factor: 13.820

4.  Phosphorylation site sequence of smooth muscle myosin light chain (Mr = 20 000).

Authors:  R B Pearson; R Jakes; M John; J Kendrick-Jones; B E Kemp
Journal:  FEBS Lett       Date:  1984-03-12       Impact factor: 4.124

5.  Ca2+, cAMP, and changes in myosin phosphorylation during contraction of smooth muscle.

Authors:  M O Aksoy; S Mras; K E Kamm; R A Murphy
Journal:  Am J Physiol       Date:  1983-09

6.  Purification and characterization of smooth muscle myosin light chain kinase.

Authors:  R S Adelstein; C B Klee
Journal:  J Biol Chem       Date:  1981-07-25       Impact factor: 5.157

7.  Statistical analysis of enzyme kinetic data.

Authors:  W W Cleland
Journal:  Methods Enzymol       Date:  1979       Impact factor: 1.600

8.  A p-methylbenzhydrylamine resin for improved solid-phase synthesis of peptide amides.

Authors:  G R Matsueda; J M Stewart
Journal:  Peptides       Date:  1981       Impact factor: 3.750

9.  Phosphorylation of myosin light chain kinase from vascular smooth muscle by cAMP- and cGMP-dependent protein kinases.

Authors:  D R Hathaway; M V Konicki; S A Coolican
Journal:  J Mol Cell Cardiol       Date:  1985-09       Impact factor: 5.000

10.  Myosin light chain phosphorylation associated with contraction in arterial smooth muscle.

Authors:  S P Driska; M O Aksoy; R A Murphy
Journal:  Am J Physiol       Date:  1981-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.